Cell ProTx is a pre-clinical stage biotechnology company developing treatments to protect human cells and tissue from damage. The company is addressing areas of unmet medical need in oncology by reducing the incidence of collateral damage to healthy tissue in the vicinity of tumors undergoing radiotherapy.